Methamphetamine-Triggered Neurotoxicity in Human Dorsolateral Prefrontal Cortex.
Apoptosis;
BDNF
Methamphetamine
Prefrontal Cortex
Journal
Galen medical journal
ISSN: 2322-2379
Titre abrégé: Galen Med J
Pays: Iran
ID NLM: 101625418
Informations de publication
Date de publication:
2021
2021
Historique:
received:
30
08
2020
revised:
14
10
2020
accepted:
09
10
2020
entrez:
2
5
2022
pubmed:
2
2
2021
medline:
2
2
2021
Statut:
epublish
Résumé
Methamphetamine (MA), is an extremely addictive stimulant that adversely affects the central nervous system. Accumulating evidence indicates that molecular mechanisms such as oxidative stress, apoptosis, and autophagy are involved in the toxicity of MA. Considering experimental animal studies exhibiting MA-induced neurotoxicity, the relevance of these findings needs to be evidently elucidated in human MA users. It is generally assumed that multiple chemical substances released in the brain following MA-induced metabolic activation are primary factors underlying damage of neural cells. Hence, this study aimed to investigate the role of autophagy and apoptosis as well as oxidative stress in the brain of postmortem MA-induced toxicity. In this study, we determine the gene expression of autophagy and apoptosis, including BECN1, MAP1ALC3, CASP8, TP53, and BAX genes in ten healthy controls and ten chronic users of MA postmortem dorsolateral prefrontal cortex (DLPFC) by real-time polymerase chain reaction. Also, we applied immunohistochemistry in formalin-fixed and paraffin-embedded human brain samples to analyze brain-derived neurotrophic factor (BDNF). Also, spectrophotometry was performed to measure glutathione (GSH) content. The expression level of apoptotic and autophagic genes (BECN1, MAP1ALC3, CASP8, TP53, and BAX) were significantly elevated, while GSH content and BDNF showed substantial reductions in DLPFC of chronic MA users. Discussion: Our data showed that MA addiction provokes transduction pathways, namely apoptosis and autophagy, along with oxidative mechanisms in DLPFC. Also, MA induces multiple functional and structural perturbations in the brain, determining its toxicity and possibly contributing to neurotoxicity. Our study showed BDNF-positive cells as well as GSH amount, displayed significant declines in DLPFC of MA user. MA addiction provokes transduction pathways, namely apoptosis and autophagy, along with oxidative mechanisms in DLPFC. However, further investigations are needed to throw light on the cellular and molecular mechanisms that act in the various regions of the addicted brain, especially in DLPFC.
Sections du résumé
Background
UNASSIGNED
Methamphetamine (MA), is an extremely addictive stimulant that adversely affects the central nervous system. Accumulating evidence indicates that molecular mechanisms such as oxidative stress, apoptosis, and autophagy are involved in the toxicity of MA. Considering experimental animal studies exhibiting MA-induced neurotoxicity, the relevance of these findings needs to be evidently elucidated in human MA users. It is generally assumed that multiple chemical substances released in the brain following MA-induced metabolic activation are primary factors underlying damage of neural cells. Hence, this study aimed to investigate the role of autophagy and apoptosis as well as oxidative stress in the brain of postmortem MA-induced toxicity.
Materials and Methods
UNASSIGNED
In this study, we determine the gene expression of autophagy and apoptosis, including BECN1, MAP1ALC3, CASP8, TP53, and BAX genes in ten healthy controls and ten chronic users of MA postmortem dorsolateral prefrontal cortex (DLPFC) by real-time polymerase chain reaction. Also, we applied immunohistochemistry in formalin-fixed and paraffin-embedded human brain samples to analyze brain-derived neurotrophic factor (BDNF). Also, spectrophotometry was performed to measure glutathione (GSH) content.
Results
UNASSIGNED
The expression level of apoptotic and autophagic genes (BECN1, MAP1ALC3, CASP8, TP53, and BAX) were significantly elevated, while GSH content and BDNF showed substantial reductions in DLPFC of chronic MA users. Discussion: Our data showed that MA addiction provokes transduction pathways, namely apoptosis and autophagy, along with oxidative mechanisms in DLPFC. Also, MA induces multiple functional and structural perturbations in the brain, determining its toxicity and possibly contributing to neurotoxicity.
Discussion
UNASSIGNED
Our study showed BDNF-positive cells as well as GSH amount, displayed significant declines in DLPFC of MA user. MA addiction provokes transduction pathways, namely apoptosis and autophagy, along with oxidative mechanisms in DLPFC. However, further investigations are needed to throw light on the cellular and molecular mechanisms that act in the various regions of the addicted brain, especially in DLPFC.
Identifiants
pubmed: 35496352
doi: 10.31661/gmj.v10i0.2016
pmc: PMC9016412
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e2016Informations de copyright
Copyright© 2021, Galen Medical Journal.
Références
Neurobiol Dis. 2015 May;77:220-7
pubmed: 25796564
Addict Biol. 2020 Jan;25(1):e12707
pubmed: 30714656
Drug Alcohol Depend. 2015 Apr 1;149:10-7
pubmed: 25736619
Hum Reprod. 2013 Apr;28(4):877-85
pubmed: 23411620
Ann Clin Psychiatry. 2008 Jul-Sep;20(3):145-55
pubmed: 18633741
PLoS One. 2010 Dec 07;5(12):e15269
pubmed: 21151866
Eur J Neurosci. 2004 Apr;19(7):1699-707
pubmed: 15078544
Cell Mol Neurobiol. 2018 Apr;38(3):579-593
pubmed: 28623429
Neurotoxicology. 2013 Jul;37:240-6
pubmed: 23721877
Neuroscience. 2018 May 1;377:197-205
pubmed: 29534975
Oxid Med Cell Longev. 2018 Jul 22;2018:4982453
pubmed: 30140365
Arch Med Sci. 2015 Dec 10;11(6):1164-78
pubmed: 26788077
Mol Psychiatry. 2003 Jun;8(6):592-610
pubmed: 12851636
Ann N Y Acad Sci. 2006 Aug;1074:234-44
pubmed: 17105920
Nat Rev Neurosci. 2011 Oct 20;12(11):652-69
pubmed: 22011681
J Addict Med. 2014 Sep-Oct;8(5):384-5
pubmed: 25026102
Neurosci Lett. 2007 Mar 13;414(3):263-7
pubmed: 17234339
Int Rev Neurobiol. 2009;88:101-19
pubmed: 19897076
Neuropharmacology. 2009;56 Suppl 1:3-8
pubmed: 18617195
J Neurochem. 2004 Jan;88(1):114-23
pubmed: 14675155
Neuropsychopharmacology. 2014 Apr;39(5):1066-80
pubmed: 24169803
Neuroscience. 2011 Aug 25;189:277-85
pubmed: 21640165
Addict Biol. 2017 Sep;22(5):1304-1315
pubmed: 27417190
Leg Med (Tokyo). 2005 May;7(3):144-50
pubmed: 15847821
Drug Alcohol Depend. 2012 Jan 1;120(1-3):35-40
pubmed: 21794992
Behav Neurol. 2015;2015:103969
pubmed: 25861156
Neurotox Res. 2005 Nov;8(3-4):199-206
pubmed: 16371314
Chem Biol Interact. 2016 Dec 25;260:163-167
pubmed: 27746146
Life Sci. 2014 Feb 27;97(1):37-44
pubmed: 23892199
Clin Toxicol (Phila). 2010 Aug;48(7):675-94
pubmed: 20849327
Int Rev Neurobiol. 2009;88:43-64
pubmed: 19897074
Neurosci Res. 2006 Feb;54(2):73-84
pubmed: 16310877
CMAJ. 2008 Jun 17;178(13):1679-82
pubmed: 18559805
J Neurosci. 2002 Oct 15;22(20):8951-60
pubmed: 12388602
Am J Psychiatry. 2003 Sep;160(9):1699-701
pubmed: 12944350